A detailed history of First Horizon Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First Horizon Corp holds 66,161 shares of ABT stock, worth $8.41 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
66,161
Previous 98,294 32.69%
Holding current value
$8.41 Million
Previous $11.4 Million 22.24%
% of portfolio
0.42%
Previous 1.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$120.51 - $136.62 $3.87 Million - $4.39 Million
-32,133 Reduced 32.69%
66,161 $8.86 Million
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $48,663 - $57,283
460 Added 0.47%
98,294 $11.4 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $284,181 - $334,808
2,611 Added 2.74%
97,834 $11.7 Million
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $472,395 - $514,775
4,499 Added 4.96%
95,223 $10.4 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $8.31 Million - $10.1 Million
90,724 New
90,724 $9.87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $223B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.